General precautions and recommendations for COVID-19 vaccines

All people should be vaccinated in health-care settings where appropriate medical treatment is available in case of allergic reactions.
An observation period of 15 minutes after vaccination should be ensured.
Reactogenicity has to be considered for HWs, occasionally leading to time off work in the 24-48 hours following vaccination.
COVID-19 vaccine is recommended for people with comorbidities, clinical trial is ongoing to further see the efficacy and safety.
Vaccination should be deferred for at least 90 days for people who previously received passive antibody therapy for COVID-19.
Vaccination should be offered regardless of a person’s history of symptomatic or asymptomatic SARS-CoV-2 infection.
People with acute PCR-confirmed COVID-19 should not be vaccinated until after they have recovered from acute illness.
Vaccination of people suffering from acute severe febrile illness (body temperature over 38.5 °C) should be postponed.